Biocept to participate in two july investment conferences

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, announces that michael nall, president and ceo, will participate at the following investment conferences: brookline capital markets newport symposium, “transformative biotech – cancer, rare diseases, and viruses,” which will feature group and one-on-one investor meetings and panel discussions with scientific and industry experts. the conference is being held in new
BIOC Ratings Summary
BIOC Quant Ranking